Back to Search
Start Over
Pre-trial quality assurance (QA) decreases dosimetric impact of delineation and dose planning variability in the STRICTLUNG/STARLUNG trials for stereotactic body radiotherapy (SBRT) of central & ultra-central lung tumors
- Source :
- Pøhl, M, Nygård, L, Schytte, T, Persson, G F, Nielsen, T B, Marquard Knap, M, Kristiansen, C, Slot Thing, R, Møller, D S, Borissova, S, Gaard-Petersen, F, Josipovic, M, Kjeldsen, R, Sand, H M B & Hoffmann, L 2021, ' Pre-trial quality assurance (QA) decreases dosimetric impact of delineation and dose planning variability in the STRICTLUNG/STARLUNG trials for stereotactic body radiotherapy (SBRT) of central & ultra-central lung tumors ', BIGART 2021, 05/10/2021-06/10/2021 .
- Publication Year :
- 2021
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Pøhl, M, Nygård, L, Schytte, T, Persson, G F, Nielsen, T B, Marquard Knap, M, Kristiansen, C, Slot Thing, R, Møller, D S, Borissova, S, Gaard-Petersen, F, Josipovic, M, Kjeldsen, R, Sand, H M B & Hoffmann, L 2021, ' Pre-trial quality assurance (QA) decreases dosimetric impact of delineation and dose planning variability in the STRICTLUNG/STARLUNG trials for stereotactic body radiotherapy (SBRT) of central & ultra-central lung tumors ', BIGART 2021, 05/10/2021-06/10/2021 .
- Accession number :
- edsair.dedup.wf.001..8f233c984df9526b27b6dbd8054120b2